Nick van Es/LinkedIn; Faizan Khan/University of Calgary
Mar 7, 2026, 15:52
Faizan Khan: The Importance of Cancer Site in Bleeding Risk Stratification for Cancer-Associated VTE
Faizan Khan, CIHR Banting Postdoctoral Fellow at University of Calgary, shared on LinkedIn about a recent article he and Nick van Es co-authored, adding:
”In a new publication from my Banting Canada postdoctoral fellowship out today in The Lancet Haematology, Nick van Es and I highlight the importance of considering different cancer sites for bleeding risk stratification in patients with cancer-associated Venous Thromboembolism.”
Title: Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated VTE
Authors: Faizan Khan, Nick van Es
Read the Full Article on The Lancet Haematology
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 7, 2026, 16:12Amr Mohamed: Common Types of Anemia
-
Jun 7, 2026, 15:50Venkateshwarlu Bairi: AVEVA Hyderabad Supports Children Living with Thalassemia and Sickle Cell Conditions
-
Jun 7, 2026, 15:48José Antonio García Erce: Hemochromatosis and Blood Donation
-
Jun 7, 2026, 15:29Marc Scherlinger: Uncovering the Immuno-Inflammatory Functions of Platelets at EULAR 2026
-
Jun 7, 2026, 15:18Huyen Nguyen: Highlights from the NCCN Cancer-Associated Venous Thromboembolic Disease Guidelines
-
Jun 7, 2026, 14:35Erica Wood: WHO Launches Landmark Action Framework to Secure Safe and Equitable Blood Supply Worldwide
-
Jun 7, 2026, 14:27Jorge Lima: Amniotic Fluid Embolism and Its Impact on Maternal and Perinatal Outcomes
-
Jun 7, 2026, 14:20Utsab Raj Panta: Navigating the A–E Classification in Acute Pulmonary Embolism
-
Jun 7, 2026, 14:19Ming Y Lim: The Burden and Impact of Bleeding in Newly Diagnosed Cancer Patients